Read + Share
Rawson JMO, Donaldson EF, O'Rear JJ, Harrington PR, et al. Independent FDA Analyses of Nirmatrelvir/Ritonavir Resistance in the Phase 2/3
Trials EPIC-HR and EPIC-SR. Clin Infect Dis 2024 Dec 17:ciae615. doi: 10.1093.
PMID: 39686795
|
 |
|
Rawson JMO, Donaldson EF, O'Rear JJ, Harrington PR, et al. Independent FDA Analyses of Nirmatrelvir/Ritonavir Resistance in the Phase 2/3
Trials EPIC-HR and EPIC-SR. Clin Infect Dis 2024 Dec 17:ciae615. doi: 10.1093.
PMID: 39686795
|
|
|
|